Vaccinia virus complement control protein ameliorates hyperacute xenorejection by inhibiting xenoantibody binding

Transplant Proc. 2002 Dec;34(8):3277-81. doi: 10.1016/s0041-1345(02)03692-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Heterophile / blood*
  • Graft Rejection / prevention & control*
  • Heart Transplantation / immunology*
  • Heart Transplantation / pathology
  • Male
  • Mice
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / therapeutic use
  • Transplantation, Heterologous / immunology*
  • Viral Proteins / therapeutic use*

Substances

  • Antibodies, Heterophile
  • Recombinant Proteins
  • Viral Proteins
  • complement-control protein, Vaccinia virus